NCT00780182

Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers

An Open-Label, Randomized, 3-Way Crossover, Single-Dose Study in Healthy Volunteers Comparing the Bioavailability of CMX001 (HDP-Cidofovir Conjugate) Delivered as a Tablet Formulation vs a Solution Formulation and the Effect of Food on CMX001 Bioavailability

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Jazz Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the bioavailability of CMX001 when administered as a tablet vs a solution and to determine the effect of a high-fat meal on CMX001 bioavailability.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	CMX001	CMX001 tablet fasted, CMX001 tablet fed, CMX001 solution fasted

Timeline

• Start date: 2008-10-01
• Primary completion: 2008-12-01
• Completion: 2009-01-01
• First posted: 2008-10-27
• Last updated: 2010-02-02

Locations

1 site across 1 country: United States